NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

I don’t think fluff PRs help. You have seen the reaction on leukapheresis clinic announcement and the news of Advent purchase. Ultimately, it all boils down to relentless execution on key strategic initiatives. Three most important ones that markets want to know in conjunction with a UK decision:

1) NICE evidence submission PR
2) Significant non dilutive funding from big pharma
3) FDA BLA submission

Everything else is noise at this point, almost 6 years from data lock. It’s almost like it’s priced in because it was expected after such a long wait, and therefore market is unlikely to react positively.

Hopefully, there will be less frustration for you moving forward once you make peace with some of this!